Dosing & Uses
Geographic Atrophy
Pending FDA approval for geographic atrophy (GA) secondary to age-related macular degeneration (AMD)
Next:
Pharmacology
Mechanism of Action
Targeted complement-3 (C3) therapy designed to regulate excessive activation of the complement cascade
Binds to complement protein C3 and its activation fragment C3b with high affinity, thereby regulating cleavage of C3 and the generation of downstream effectors of complement activation
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
